Elucid

Just dropped 🎤 Tune in to the latest episode of Donut of Destiny, featuring @amir_ahmadi__: donutofdestiny.buzzsprout.com/874432/episode… This conversation highlights the concept of the field's transitional journey from CT 1.0 to CT 2.0 to CT 3.0 and the importance of validation and reproducibility. The key is moving from identifying anatomy to understanding biology, and finally to enabling truly personalized cardiovascular care. Dr. Ahmadi, together with host @PraveenRangana9, explore a roadmap featuring the evolution of AI-enabled CCTA into a comprehensive decision-support platform for prevention, intervention, and longitudinal disease management. Listen to learn more! Thank you @Heart_SCCT and Dr. Ranganath for yet another fantastic discussion🫀 #yesCCT #cardiotwitter #preventivecardiology

Hot off the press ♨️ Blake Richards, COO, deep dives into how #AIinHealthcare is moving beyond hype, and into the realities of clinical practice. Explore how advanced CCTA and AI-driven plaque analysis are helping shift cardiovascular care toward earlier detection and more personalized decision-making 🩺 As AI adoption accelerates, the future belongs to technologies that are not just innovative, but clinically actionable, explainable, and built for real-world care. Read more in @MedEconomics: medicaleconomics.com/view/making-ai… TL;DR: What it actually takes for AI diagnostics to succeed in the real world: strong evidence, reimbursement, workflow integration, and physician trust. Thank you @tshryock! #cardiology #CCTA #yesCCT #preventivecardiology #precisionmedicine

We’re honored to share that Plaque-IQ™ has been named “Best New Cardiology Technology Solution” in the 10th annual @MedTech_Awards 🎉 By providing insight into plaque biology, including high-risk features like lipid rich necrotic core, Plaque-IQ helps physicians make more informed, patient-specific decisions to prevent heart attack and stroke 🫀🧠 As CVD remains the leading cause of death worldwide, we’re proud to be part of the shift toward earlier detection and more personalized care. Want to learn more? Reach out to demo our technology and join us on our mission! Read the news here: elucid.com/elucid-medtech… #HistologyMatters #MedTech #Cardiology #CCTA #PrecisionMedicine #HealthcareInnovation

It’s always inspiring to spend time with teams who are pushing cardiovascular care forward. Thank you @MidwestCardio for your partnership and for your commitment to bringing more precise, patient-specific insights into everyday care! #cardiology #cardiovascularcare #yescct #precisionmedicine

Our office will be closed on Monday, April 20th, for Patriot's Day - and for the 130th #BostonMarathon! This one is very special for us, as our very own Sonal Ambwani will be racing this year! Many of us will be watching from around the city, cheering her on. Good luck, Sonal 🫶 - see you at the finish line! 👟🦄 #TeamElucid

Dr. Robert Pelberg, SVP of Medical Affairs, shares his outlook on the critical shift in how we understand and assess cardiovascular disease with @DAICeditor. Read here: dicardiology.com/article/beyond… Three key takeaways: 🫀 A large percentage of heart attacks don’t come from severe blockages. Many events originate from plaques that were previously non–flow limiting (<50% stenosis), exposing the limits of a stenosis-only approach. 🔬 Plaque biology drives risk. Features like lipid-rich necrotic core and plaque structure are key determinants of vulnerability, even when arteries appear only mildly narrowed. 🔎 Advanced imaging is enabling a new paradigm. #CCTA and emerging technologies like Elucid's Plaque-IQ are expanding the ability to assess plaque burden and composition, offering a more complete view of disease. #Cardiology #CoronaryPlaque #PreventiveCardiology #CardiovascularImaging #PrecisionMedicine

🚨 News just announced! 🚨 We're excited to introduce the commercial availability of our Lesion Inspection Tool for Plaque-IQ™, bringing lesion-level plaque analysis directly to physicians. Read more: elucid.com/elucid-lesion-… 🔎 This new capability enables clinicians to interrogate individual lesions, quantify plaque composition, including high-risk features like lipid-rich necrotic core (LRNC), and gain deeper insight into a patient’s true disease burden. Plaque-IQ continues to advance more precise, personalized cardiovascular care, helping physicians better assess risk and guide treatment decisions. 🫀🧠 #Cardiology #CCTA #yesCCT #PlaqueAnalysis #PrecisionMedicine #CardiovascularImaging

Today is the @WHO's #WorldHealthDay, a moment to celebrate health advances rooted in science. At Elucid, this belief is at the core of everything we do. Our technology is built on #histology, the gold standard for understanding disease at the tissue level. By translating histological insight into CT-based plaque analysis, we’re helping physicians better understand plaque, assess individual risk, and make more informed, patient-specific treatment decisions. #CardiovascularHealth #PrecisionMedicine #MedicalInnovation #HistologyMatters #yesCCT

Today is the @WHO's #WorldHealthDay, a moment to celebrate health advances rooted in science. At Elucid, this belief is at the core of everything we do. Our technology is built on #histology, the gold standard for understanding disease at the tissue level. By translating histological insight into CT-based plaque analysis, we’re helping physicians better understand plaque, assess individual risk, and make more informed, patient-specific treatment decisions. #CardiovascularHealth #PrecisionMedicine #MedicalInnovation #HistologyMatters #yesCCT

That’s a wrap at #ACC26! Thank you to all who stopped by to learn about what we can do together! We’re feeling recharged by all the great energy in New Orleans. See you all next year in Houston! 🤠 Thank you @ACCinTouch for putting together another phenomenal meeting. #histologymatters

Kicking off day✌️of #ACC26! Our team is easy like Sunday morning, but pumped and excited for another busy day at ACC. Stop by and see us if you’re at the show! ☀️🎉

We’re live and ready to go at #ACC26!! Come by booth 743 to see how our histology-based Plaque-IQ can be applied to your CT program for heart attack and stroke prevention! Enjoy ACC 🫀🧠 #histologymatters

🗓️ ACC.26 is this week! Visit us at booth 743 to experience Plaque-IQ, the only histology-based coronary and carotid plaque analysis software designed to help physicians identify and characterize arterial plaques at risk for heart attack and stroke. 🫀 🧠 Message us to make an appointment, or email us at info@elucid.com. Visit elucid.com for more info.

A new JACC Journals: Case Reports publication highlights an important reality in #cardiovascularcare: high-risk coronary disease can be clinically silent. In this case, advanced coronary CT imaging revealed extensive plaque dominated by lipid-rich necrotic core (#LRNC), a key marker of vulnerable plaque and future coronary events. Read here: sciencedirect.com/science/articl… Key takeaways: • Severe coronary disease may exist without symptoms, underscoring the limits of symptom-based detection • LRNC is a critical marker of plaque vulnerability and future risk • Advanced coronary imaging can reveal hidden disease earlier, enabling more proactive management Studies like this reinforce the importance of detecting true disease earlier—before heart attack or stroke occurs. Congrats to the authors! Drs. @elisarrarasx, Robert Pelberg, Jacob S. Roberts, @JayShah_MD, Jeffrey Xia, Sammy Sayed, Norman Lepor, Jairo Aldana-Bitar, @RonKarlsbergMD, Geoffrey Cho #Cardiology #CCTA #CoronaryPlaque #PreventiveCardiology #CardiovascularImaging #CAD

❤️ We’re grateful to support a cause that’s truly close to our hearts, made possible by the continued generosity of the Elucid team. In honor of #AmericanHeartMonth, we’re assembling #BraveryBags for the @MendedHearts community at @BostonChildrens, helping bring comfort to young patients and their families. Moments like this are a powerful reminder of why we do what we do. Taking time to #giveback keeps us grounded in our mission to help physicians improve cardiovascular care. Looking forward to delivering these soon!! 🫶 #TeamElucid #ElucidCares

Check out a podcast i was featured in about coronary artery calcium scanning podcasts.apple.com/us/podcast/292…

🩺 Tune in as Dr. Bon-Kwon Koo, MD, PhD, Professor of Cardiology at Seoul National University walks us through what it takes to truly personalize a patient's treatment plan, combining insights from CT angiography, physiology, and advanced imaging analysis. #yesCCT #plaqueanalysis 👉 Find out more about how Elucid's Plaque-IQ can help support your CT program by visiting elucid.com or by sending us a direct message here! 🫀 Ask us why #histologymatters - Plaque-IQ is the only solution objectively validated against tissue samples, the gold standard for plaque characterization, allowing physicians to measure true disease rather than indirect proxies.

❤️ Heart disease remains the leading cause of death worldwide. During #AmericanHeartMonth, Elucid stands with @American_Heart to raise awareness of the importance of early, personalized cardiovascular care. We're also excited to continue our tradition of supporting @MendedHearts Bravery Bags initiative. Learn more about the program here: mendedhearts.org/treatmentsuppo…

Thank you @MedicalTechMag for an insightful conversation with Kelly Huang, PhD, right on time to kick off American Hearth Month in February! As we all have seen, a major shift in coronary artery disease care is underway. Recent reimbursement decisions for coronary plaque analysis signal a clear move toward more precise plaque-based diagnosis. 🔹 Reimbursement unlocks adoption: With coverage now in place, clinicians can more easily use quantitative plaque analysis to identify high-risk disease sooner. 🔹 With histology-validated Plaque-IQ™, Elucid is helping redefine how coronary disease is detected, managed, and prevented. The future of CAD care is proactive, precise, and plaque-based. Read more: medicaldevice-network.com/news/coronary-… #PrecisionCardiology #PlaqueAnalysis #CardiacImaging #MedTech #HealthcareInnovation #cardiotwitter